Patent Assignment
Reel/Frame 062347/0129
Release of Security Interest
Recorded: 2023-01-11
Pages: 19
Assignor
EVENING POST GROUP, LLC
Executed: 2023-01-11
Assignee
EPI HEALTH, LLC
134 COLUMBUS STREET, CHARLESTON, SOUTH CAROLINA, 29403
Covered Properties
(36)
Prolonged Release Bioadhesive Therapeutic Systems
Non-Toxic Hydrophobic Elastomeric Polymer Chemistry System for Wood Preservation
Method and Therapeutic/Cosmetic Topical Compositions for the Treatment of Rosacea and Skin Erythema Using A1-Adrenoceptor Agonists
Method for the Treatment of Acne
Minocycline Oral Dosage Forms for the Treatment of Acne
Minocycline Oral Dosage Forms for the Treatment of Acne
Minocycline Oral Dosage Forms for the Treatment of Acne
Poly(Urea-Urethane) Compositions Useful as Topical Medicaments and Methods of Using the Same
Minocycline Oral Dosage Forms for the Treatment of Acne
Compositions and Methods for Treating Purpura
Method for the Treatment of Acne and Certain Dosage Forms Thereof
Mucoadhesive Buccal Tablets for the Treatment of Orofacial Herpes
Mucosal Bioadhesive Slow Release Carrier for Delivering Active Principles
Method and Therapeutic/Cosmetic Topical Compositions for the Treatment of Rosacea and Skin Erythema Using A1-Adrenoceptor Agonists
Extended-Release Minocycline Dosage Forms
Patent:
8,722,650 →
Application:
12/861,424 →
Minocycline Oral Dosage Forms for the Treatment of Acne
Method and Therapeutic/Cosmetic Topical Compositions for the Treatment of Rosacea and Skin Erythema Using A1-Adrenoceptor Agonists
Method and Therapeutic/Cosmetic Topical Compositions for the Treatment of Rosacea and Skin Erythema Using A1-Adrenoceptor Agonists
Pharmaceutical Cream Compositions and Methods of Use
Compositions and Methods for Treating Purpura
Mucosal Bioadhesive Slow Release Carrier for Delivering Active Principles
Mucosal Bioadhesive Slow Release Carrier for Delivering Active Principles
Compositions and Methods for Treating Purpura
Poly(Urea-Urethane) Compositions Useful as Topical Medicaments and Methods of Using the Same
Pharmaceutical Cream Compositions and Methods of Use
Application:
14/521,094 →
Publication:
US 2015/0045403
Stabilized Oxymetazoline Formulations and Their Uses
Methods of Treating and/or Preventing Nail Disorders and/or Improving the Appearance of a Nail
Pharmaceutical Compositions for Minocycline
Stabilized Oxymetazoline Formulations and Their Uses
Stabilized Oxymetazoline Formulations and Their Uses
Stabilized Oxymetazoline Formulations and Their Uses
Pharmaceutical Cream Compositions of Oxymetazoline and Methods of Use
Pharmaceutical Cream Compositions and Methods of Use
Application:
16/798,176 →
Publication:
US 2020/0188517
Method and Therapeutic/Cosmetic Topical Compositions for the Treatment of Rosacea and Skin Erythema Using A1-Adrenoceptor Agonists
Application:
16/857,968 →
Publication:
US 2021/0069186
Stabilized Oxymetazoline Formulations and Their Uses
Pharmaceutical Compositions for Minocycline
Application:
17/388,133 →
Publication:
US 2021/0353649
Related Assignments
(23)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Jul 19, 2017
From: MEDICIS PHARMACEUTICAL CORPORATION
To: THE BANK OF NEW YORK MELLON
Reel/Frame 043239/0675 →
Security Interest
Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
Security Interest
Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
Assignment of Assignor's Interest
Jul 16, 2018
From: ONXEO
To: VECTANS PHARMA
Reel/Frame 046355/0197 →
Security Interest
Oct 12, 2018
From: VECTANS PHARMA
To: ONXEO
Reel/Frame 047145/0653 →
Assignment of Assignor's Interest
Dec 5, 2018
From: ALLERGAN, INC.
To: ACLARIS THERAPEUTICS, INC.
Reel/Frame 047681/0466 →
Security Interest
Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
Assignment of Assignor's Interest
Nov 1, 2019
From: ACLARIS THERAPEUTICS, INC.
To: EPI HEALTH, LLC
Reel/Frame 050905/0290 →
Assignment of Assignor's Interest
Feb 26, 2020
From: VECTANS PHARMA
To: EPI HEALTH, LLC
Reel/Frame 051939/0848 →
Release of Security Interest
Mar 4, 2020
From: ONXEO
To: VECTANS PHARMA
Reel/Frame 052091/0214 →
Security Interest
Jun 8, 2021
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 056811/0814 →
Security Agreement
Feb 10, 2022
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION
To: THE BANK OF NEW YORK MELLON
Reel/Frame 059121/0001 →
Security Interest
Mar 14, 2022
From: EPI HEALTH, LLC
To: EVENING POST GROUP, LLC
Reel/Frame 059364/0509 →
Security Agreement (First Lien)
Oct 4, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061595/0066 →
Security Agreement (Second Lien)
Oct 5, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061606/0468 →
Assignment of Assignor's Interest
Jan 18, 2024
From: EPI HEALTH, LLC
To: LNHC, INC.
Reel/Frame 066350/0609 →
Release of Security Interest
Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →
Assignment of Assignor's Interest
May 30, 2025
From: LNHC, INC.
To: LIGAND PHARMACEUTICALS INCORPORATED
Reel/Frame 071481/0040 →
U.S. Patent Security Agreement
Jun 13, 2025
From: MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; BAUSCH HEALTH US, LLC (F/K/A VALEANT PHARMACEUTICALS NORTH AMERICA LLC); PRECISION DERMATOLOGY, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 071566/0200 →
U.S. Patent Security Agreement
Jun 13, 2025
From: MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; BAUSCH HEALTH US, LLC (F/K/A VALEANT PHARMACEUTICALS NORTH AMERICA LLC); PRECISION DERMATOLOGY, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 071564/0463 →
Release of Security Interest
Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
Reel/Frame 073637/0126 →
Release of Security Interest
Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
Reel/Frame 073637/0001 →
Release of Security Interest
Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION
Reel/Frame 073654/0242 →